The Coronavirus Aid, Relief and Economic Security (CARES) Act, H.R. 748, was enacted by Congress on March 27, 2020. Subsequently, interim guidance continues to be released by the Treasury and Small Business Administration (SBA). Presented below are FAQs which address questions arising in relation to business valuation, followed by a summary of four key CARES Act provisions with additional FAQs. The information provided below is not a substitute for the valuation analyst’s experience or professional judgement. Further research and analysis
Resources
Valuation considerations related to the CARES Act
Jun 03, 2020 · 18 min read
FREE ACCOUNT
ACCESS
Already a member?
Log in with your account
Not a member?
To gain access to exclusive content, your first step is to join the AICPA & CIMA.